Vonjo (pacritinib) improves hemoglobin levels in myelofibrosis patients with anemia, aligning with clinical guidelines for anemia management. The study showed 44% of patients achieved a hemoglobin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results